MGTX Stock Analysis: Buy, Sell, or Hold?
MGTX - MeiraGTx Holdings plc Ordinary Shares
$12.44
0.10 (0.81%)
▲
5d:
-15.14%
30d:
+29.58%
90d:
+29.18%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When MGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MGTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MGTX is down 15.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MGTX is down 15.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MGTX is currently trading at $12.44, which is considered fair relative to its 30-day fair value range of $9.85 to $13.45.
Technical Outlook: Technically, MGTX is in a strong uptrend. The price is currently testing key support at $12.17. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $28.38 (+128.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MGTX is in a strong uptrend. The price is currently testing key support at $12.17. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $28.38 (+128.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$9.85 -
$13.45
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 128.1% below Wall St target ($28.38)
- WARNING: Recommendation downgraded due to -15.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$9.85 -
$13.45
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$12.17
Resistance Level
$15.35
Current Trend
Strong Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.10
Wall Street Target
$28.38
(+128.1%)
Revenue Growth (YoY)
-84.8%
Profit Margin
-151.1%
Share & Embed Analysis
Last updated: July 14, 2026 6:01 PM ET
Data refreshes hourly during market hours. Next update: 7:01 PM
Data refreshes hourly during market hours. Next update: 7:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard Giroux
SELL
56000 shares
2026-04-21
Stuart Naylor
SELL
27661 shares
2026-04-07
Alexandria Forbes
SELL
62000 shares
2026-03-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 58 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
